These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16550042)

  • 41. Sequential liver-kidney transplantation.
    Salizzoni M; Gennari F; Liddo G; Mirabella S; Brunati A; Strignano P; Cerutti E
    Transplant Proc; 2004 Apr; 36(3):543-4. PubMed ID: 15110587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver transplantation: an update 2009.
    Skagen C; Lucey M; Said A
    Curr Opin Gastroenterol; 2009 May; 25(3):202-8. PubMed ID: 19349862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C.
    Burra P
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The natural history of recurrent hepatitis C and what influences this.
    Gane EJ
    Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current status of thoracic organ transplantation and allocation in the United States.
    Coke M; Edwards LB
    Clin Transpl; 2004; ():17-26. PubMed ID: 16704135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
    Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN; Perkins JD; Carithers RL
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation for hepatocellular carcinoma.
    Heimbach JK
    Cancer J; 2008; 14(2):95-9. PubMed ID: 18391614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update in liver transplantation.
    Alqahtani SA
    Curr Opin Gastroenterol; 2012 May; 28(3):230-8. PubMed ID: 22450898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver transplant for viral hepatitis and fulminant hepatic failure.
    Mukherjee S; Mahmoudi TM; Mukherjee U
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):83-100. PubMed ID: 19212311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Advances and limitations of liver transplantation in Germany].
    Beckebaum S; Cicinnati VR; Broelsch CE
    Verh Dtsch Ges Pathol; 2004; 88():45-50. PubMed ID: 16892533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis C and liver transplantation.
    Brown RS
    Nature; 2005 Aug; 436(7053):973-8. PubMed ID: 16107838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.
    Novelli G; Rossi M; Pugliese F; Poli I; Ruberto E; Martelli S; Nudo F; Morabito V; Mennini G; Berloco PB
    Transplant Proc; 2007; 39(6):1864-7. PubMed ID: 17692635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Should liver transplantation in patients with model for end-stage liver disease scores Perkins JD; Halldorson JB; Bakthavatsalam R; Fix OK; Carithers RL; Reyes JD
    Liver Transpl; 2009 Feb; 15(2):242-54. PubMed ID: 19177441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modern renal transplantation: present challenges and future prospects.
    Galliford J; Game DS
    Postgrad Med J; 2009 Feb; 85(1000):91-101. PubMed ID: 19329704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.